Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 6/20 | 0.64 |
| ▸ | TSHR | P16473 | 3/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | MAOA | P21397 | 1/20 | 0.57 |
| ▸ | HTR3A | P46098 | 1/20 | 0.57 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | SCN1A | P35498 | 1/20 | 0.55 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.55 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nicametate SCHEMBL5060940 | 1.00 | L3MBTL1 (0.68) | L3MBTL1LMNATSHRCYP2D6MAOA | |
| Nicametate SCHEMBL28346401 | 0.96 | L3MBTL1 (0.63) | L3MBTL1LMNATSHRCYP2D6MAOA | |
| Nicametate SCHEMBL194781 | 0.87 | KDM4E (0.56) | L3MBTL1LMNATSHRCYP2D6MAOA | |
| SCHEMBL3079077 | 0.86 | MAPT (0.62) | LMNATSHRCYP2D6MAOAHTR3A | |
| Procaine SCHEMBL9312338 | 0.86 | CYP2D6 (0.69) | L3MBTL1LMNATSHRCYP2D6MAOA | |
| SCHEMBL9717097 | 0.85 | L3MBTL1 (0.67) | L3MBTL1LMNAKMT2AMEN1ALDH1A1 | |
| Procaine SCHEMBL9312532 | 0.85 | BLM (0.70) | L3MBTL1LMNATSHRCYP2D6MAOA | |
| SCHEMBL382067 | 0.83 | L3MBTL1 (0.82) | L3MBTL1LMNATSHRKMT2AMEN1 | |
| SCHEMBL25009812 | 0.83 | L3MBTL1 (0.76) | L3MBTL1LMNACYP2D6KMT2AMEN1 | |
| SCHEMBL30556174 | 0.83 | L3MBTL1 (0.76) | L3MBTL1LMNACYP2D6KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2484 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4525921-A1 | PEPTIDE-IONIC LIQUID CONJUGATE FOR THE PREVENTION AND/OR TREATMENT OF SKIN DISORDERS | Universidade Do Porto (PT) | 2025-03-26 | — | — | EP | claimed |
| CN-119438596-A | Quick detection method for bacterial drug resistance by combining short-time antibiotic stimulated bacterial metabolism fingerprint spectrum with machine learning | 复旦大学 | 2025-02-14 | — | — | CN | claimed |
| EP-3607084-B1 | A METHOD FOR TESTING ANTIMICROBIAL SUSCEPTIBILITY | UNIV WESTERN AUSTRALIA (AU) | 2024-05-01 | — | — | EP | claimed |
| CN-117887673-A | Shiga toxin-producing escherichia coli bacteriophage and application thereof in elimination of drug-resistant bacteria | 青岛农业大学 | 2024-04-16 | — | — | CN | claimed |
| US-11959122-B2 | Method for assessing microbial drug resistance multi-level risks of antibiotic residues in water environment | Nanjing Institute Of Environmental Sciences, Mee (CN) | 2024-04-16 | — | — | US | claimed |
| WO-2023248196-A1 | PEPTIDE-IONIC LIQUID CONJUGATE FOR THE PREVENTION AND/OR TREATMENT OF SKIN DISORDERS | UNIVERSIDADE DO PORTO (PT) | 2023-12-28 | — | — | WO | claimed |
| US-20230392183-A1 | METHOD FOR ASSESSING MICROBIAL DRUG RESISTANCE MULTI-LEVEL RISKS OF ANTIBIOTIC RESIDUES IN WATER ENVIRONMENT | Nanjing Institute Of Environmental Sciences, Mee (CN) | 2023-12-07 | — | — | US | claimed |
| WO-2023183932-A2 | MONOBODIES BINDING TO INTERCELLULAR ADHESION MOLECULE 2 (ICAM-2) | NEW YORK UNIVERSITY (US) | 2023-09-28 | — | — | WO | claimed |
| CN-115062933-B | Multi-level risk assessment method for microbial drug resistance of antibiotic residues in water environment | 生态环境部南京环境科学研究所 | 2023-04-18 | — | — | CN | claimed |
| CN-115505628-A | Combined drug susceptibility test method for rapidly detecting synergistic effect of aztreonam and ceftazidime-abamectin | 刘周 | 2022-12-23 | — | — | CN | claimed |
| EP-1385501-A2 | PROBUCOL MONOESTERS AND THEIR USE TO INCREASE PLASMA HDL CHOLESTEROL LEVELS AND IMPROVE HDL FUNCTIONALITY | Atherogenics, Inc. (US) | 2004-02-04 | — | — | EP | claimed |
| WO-2003097714-A1 | FAT BINDING USING INTER-POLYMER COMPLEX OF GLUCOSAMINE AND POLYACRYLIC ACID | RANBAXY LABORATORIES LIMITED (IN) | 2003-11-27 | — | — | WO | claimed |
| US-20030162824-A1 | Methods of treating or preventing a cardiovascular condition using a cyclooxygenase-1 inhibitor | PHARMACIA CORPORATION | 2003-08-28 | — | — | US | claimed |
| WO-2002087556-A9 | PROBUCOL MONOESTERS AND THEIR USE TO INCREASE PLASMA HDL CHOLESTEROL LEVELS AND IMPROVE HDL FUNCTIONALITY | ATHEROGENICS INC (US) | 2003-03-20 | — | — | WO | claimed |
| WO-2002087556-A2 | PROBUCOL MONOESTERS AND THEIR USE TO INCREASE PLASMA HDL CHOLESTEROL LEVELS AND IMPROVE HDL FUNCTIONALITY | ATHEROGENICS, INC. (US) | 2002-11-07 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-5938791-A | Device for detecting margin of information recording and reproducing apparatus | SONY CORPORATION (JP) | 1999-08-17 | — | — | US | claimed |
| EP-0007109-A1 | Apparatus for metering a solution of chemicals to a stream of liquid | LANG APPARATEBAU GMBH (DE) | 1980-01-23 | — | — | EP | claimed |